Salient Features of New Therapies in Ophthalmology

Abstract

Although glaucoma is a leading cause of blindness worldwide, yet there are no large databases where risk factors, current management options and outcomes may be evaluated. With this concept in mind, Dallas Glaucoma Registry [4] was established to focus on an ethnically mixed North Texas population. Large numbers of patients in the ongoing Dallas Glaucoma Registry do provide adequate data to better understand risk factors, early detection, improved screening targets, treatment options, outcomes and future studies.A case study was done to evaluate the choroidal thickness changes in the eyes with myopic choroidal neovascularization [5] (mCNV) after AbstractThis review gives the information regarding the therapies that are used against ophthalmological disorders and along with that it helps us to update ourselves to know more about the salient features of the therapies, drugs and diagnosis methodologies. This review also shares information regarding the various eye related diseases like substantial changes in corneal structure, glaucoma, cataract and age-related macular degeneration and many other and along with that the remedial therapies like Refractive laser surgery, in Polypoidal Choroidal Vasculopathy (PCV), Ranibizumab and Panretinal laser photocoagulation etc.